Anaesthetic Gas Exposure SWMS
Waste anaesthetic gas (WAG) management in operating theatres, recovery rooms, procedure suites, and dental surgeries. Covers scavenging system inspection and integrity testing, closed-circuit technique enforcement, passive or active scavenging selection, air-monitoring frequency, pregnant-worker exposure assessment and reassignment, and AS 1668.2 theatre ventilation verification. Includes leak-testing procedures for anaesthetic machines and low-flow anaesthesia technique guidance.
SWMS variants reference your state's WHS legislation. Instant download after payment.
This SWMS covers the management of waste anaesthetic gas (WAG) exposure in Australian operating theatres, procedure rooms, recovery areas, day-surgery units, dental surgeries, and veterinary practices. It is written for anaesthetists, nurse anaesthetists, theatre nurses, anaesthetic technicians, recovery room nurses, dental practitioners, dental assistants, and any worker who is present in a space where anaesthetic gases are administered, vented, or scavenged. Every task has been authored against the Model WHS Regulations Part 7.1 (Hazardous Chemicals), the SWA Workplace Exposure Standards for nitrous oxide (25 ppm TWA, 100 ppm STEL) and halogenated volatile anaesthetic agents (isoflurane, sevoflurane, desflurane — 2 ppm TWA), AS 1668.2 (Mechanical ventilation and air conditioning in buildings — Part 2: Mechanical ventilation for acceptable indoor-air quality), and the Australian and New Zealand College of Anaesthetists (ANZCA) Professional Document PS31 (Recommendations for the safe management of waste anaesthetic gases).
Waste anaesthetic gas exposure is a recognised chronic occupational health risk for theatre personnel. Nitrous oxide is a human reproductive toxin at sustained occupational exposure levels — female workers exposed above the WES have documented increased rates of spontaneous abortion, reduced fertility, and congenital abnormality in offspring. Halogenated agents (isoflurane, sevoflurane, desflurane) are associated with liver toxicity at high exposure levels and are classified as potential occupational carcinogens at chronic low-level exposure. The primary exposure pathway is inhalation of gas leaking from anaesthetic machine connections, poorly maintained breathing circuits, poorly fitting face masks, and malfunctioning or absent scavenging systems. This SWMS provides a maintenance, monitoring, and engineering-control programme that targets the elimination of unnecessary WAG exposure while maintaining clinical workflow.
Hazards identified
12 hazards covered, sorted by priority.
Spontaneous abortion, reduced fertility, and congenital abnormality in children born to female workers chronically exposed above the SWA TWA; male reproductive effects (reduced sperm count) at sustained high exposure.
Occupational liver disease and potential carcinogenic risk from sustained inhalation of isoflurane, sevoflurane, or desflurane above 2 ppm TWA; desflurane is the highest-potency agent and generates the most WAG in high-flow technique.
Rapid accumulation of theatre-air WAG concentration to multiples of the WES when active or passive scavenging fails; highest risk for pregnant workers who may not be aware of the reproductive toxicity threshold.
Sustained micro-leak from breathing circuit connections, cracked reservoir bags, or poorly seated vaporiser fillers releases WAG continuously during procedure; ambient concentration accumulates across a list of cases.
During mask induction the patient exhales unscavenged gas into the ambient theatre air; nitrous oxide and volatile agent concentrations spike during induction and emergence phases if mask seal is poor or mask is held away from the patient's face.
Pregnant theatre worker exposed above the reproductive toxicity threshold without the employer's knowledge; no task reassignment or additional monitoring implemented; preventable reproductive outcome.
Recovery nurses exposed to nitrous oxide and volatile agents exhaled by patients awakening from anaesthesia in areas where ventilation achieves fewer than 15 air changes per hour.
Dental staff exposed to nitrous oxide during conscious sedation procedures where a nasal mask with no scavenging attachment is used; dental surgeries frequently under-monitored for WAG compliance.
Anaesthetic machine integrity check not performed or performed inadequately; circuit leak present during subsequent case list causing sustained ambient WAG elevation throughout the session.
WAG accumulation in theatres where ventilation falls below the AS 1668.2 minimum of 20 air changes per hour due to HVAC fault, filter blockage, or damper failure; air monitoring records do not detect the fault between annual surveys.
Liquid volatile anaesthetic spilled during vaporiser filling volatilises rapidly, creating a local high-concentration aerosol; inhalation of liquid anaesthetic aerosol causes acute respiratory irritation and central nervous system depression.
Cylinder valve struck or damaged during transport or storage causing uncontrolled nitrous oxide release; risk of asphyxiation in confined spaces and pressure explosion if cylinder becomes projectile.
Control measures
Hierarchy-of-controls order: elimination → substitution → isolation → engineering → administrative → PPE.
- 1Scavenging system — active or passive scavenging installed at every anaesthetic machine and procedure room where volatile anaesthetic or nitrous oxide is administered; passive scavenging adequate for machines with <2 L/min fresh gas flow; active scavenging required for high-fresh-gas or paediatric techniques. Scavenging system capacity and connection to exterior vent confirmed by biomedical engineering at commissioning.
- 2Pre-list machine leak test — mandatory low-pressure leak test performed before every anaesthetic list and after any circuit change, in accordance with ANZCA PS31 and the specific machine's operating manual. Leak test result documented on the theatre schedule.
- 3AS 1668.2 ventilation compliance — operating theatres verified to achieve minimum 20 air changes per hour (minimum 4 of which are outdoor air) per AS 1668.2; HVAC system inspected and ventilation rate confirmed by facilities management at minimum annually; certificate posted in theatre.
- 4Recovery room ventilation — recovery areas to achieve minimum 15 air changes per hour; exhaled-patient WAG treated as a continuous emission source during the immediate post-anaesthetic period; recovery nurses rotate positions to avoid prolonged proximity to unventilated patient head.
- 5Closed-circuit and low-flow technique — anaesthetists encouraged to use low fresh-gas-flow technique (≤1 L/min) and closed-circuit delivery where clinically appropriate to reduce WAG generation at source; WAG generation is proportional to fresh-gas-flow rate.
- 6Pregnancy declaration protocol — voluntary written declaration to department head triggers WAG risk review, air monitoring results briefing, and task reassignment if current monitoring shows concentrations above reproductive toxicity threshold; additional personal air monitoring offered to the declared worker for the duration of the pregnancy.
- 7Annual WAG air monitoring — personal exposure monitoring conducted by a NATA-accredited industrial hygienist annually for each high-exposure role (anaesthetist, theatre nurse, recovery nurse, dental nurse); monitoring results compared to SWA WES; corrective action required within 30 days if any result exceeds 50% of WES.
- 8Vaporiser filling protocol — volatile anaesthetic vaporiser filled using a closed-circuit keyed filler device (Quik-Fil or equivalent) that prevents liquid spillage; filling performed in the anaesthetic room with the door to theatre closed; nitrile gloves and safety goggles worn during filling.
- 9Nitrous oxide cylinder handling — N₂O cylinders transported on a trolley, never dragged or rolled; valve caps replaced when not in use; cylinders stored upright in a ventilated, secure store away from heat sources; ANZCA cylinder safety procedures posted at the gas manifold.
- 10Exposure incident response — any suspected acute WAG exposure (dizziness, headache, nausea during a case) triggers immediate removal from the theatre, fresh-air rest, and biomedical engineering inspection of the anaesthetic machine and scavenging system before the list resumes.
- 11Maintenance programme — anaesthetic machines serviced per manufacturer schedule (typically annually by biomedical engineering); scavenging hose, reservoir bag, and breathing circuit replaced per manufacturer intervals; maintenance log retained at machine.
Applicable Codes of Practice
Sets the TWA WES for nitrous oxide (25 ppm / 100 ppm STEL) and halogenated volatile agents (isoflurane, sevoflurane, desflurane — 2 ppm TWA) referenced throughout this SWMS.
Primary clinical guidance for anaesthetic gas management; sets out machine check requirements, scavenging standards, air-monitoring frequency, and pregnancy protocols.
Sets the minimum ventilation rates (20 ACH for operating theatres, 15 ACH for recovery) referenced in the engineering controls section.
Regulatory basis for the duty to manage WAG as a hazardous chemical; SDS management, exposure monitoring, health surveillance, and incident reporting obligations.
Who this is for
- →Anaesthetists and nurse anaesthetists administering inhalational anaesthesia in operating theatres, procedure rooms, and dental surgeries.
- →Theatre nurses and anaesthetic technicians circulating or scrubbing in rooms where volatile anaesthetics are in use.
- →Recovery room nurses managing immediate post-anaesthetic patients who are actively exhaling residual anaesthetic agent.
- →Dental practitioners and dental assistants administering nitrous oxide conscious sedation using nasal masks.
- →Theatre managers, biomedical engineers, and WHS officers responsible for anaesthetic machine maintenance, scavenging systems, and WAG monitoring programmes.
What you receive
- ✓Editable Microsoft Word (.docx) document delivered within 24 hours of payment.
- ✓Title page with facility name, ABN, department, and revision date fields.
- ✓Signed approval block for theatre manager, anaesthetic department head, and WHS officer.
- ✓Hazard register with the 12 hazards above, each with consequence, inherent risk, controls, and residual risk scored on a 5×5 likelihood-consequence matrix.
- ✓Pre-list machine leak test procedure and documentation template aligned to ANZCA PS31.
- ✓Annual WAG air monitoring schedule and result tracking table (by role and theatre).
- ✓Scavenging system inspection checklist — active and passive systems.
- ✓Pregnancy declaration procedure template and WAG risk briefing document.
- ✓Vaporiser filling safety procedure card formatted for lamination at the anaesthetic machine.
- ✓State-by-state hazardous chemicals legislation variance table (NSW, VIC, QLD, WA, SA, TAS, ACT, NT).
Worked example
A 34-year-old theatre nurse in a Melbourne private hospital, 8 weeks pregnant and not yet declared, notices recurring mild headaches during morning theatre lists. She reviews the WAG monitoring results posted in the theatre lounge — the last annual survey (7 months ago) showed nitrous oxide at 18 ppm TWA (below 25 ppm WES) and sevoflurane at 1.4 ppm (below 2 ppm WES). She speaks to the anaesthetic department head, who conducts a walk-through: the scavenging hose on Machine 2 has a partial disconnect discovered during a breathing circuit change. This explains the elevated headaches. The hose is replaced immediately; a leak test is performed and passed. She declares her pregnancy to the department head; her WAG exposure risk briefing is conducted; and an additional personal air monitoring session is booked for the following week. Her duties are adjusted to avoid the recovery room during the declared pregnancy until the next annual survey confirms concentrations below reproductive thresholds.
Related legislation
- Work Health and Safety Regulation 2017 (NSW) Part 7.1 — hazardous chemicals management including WAG; health monitoring obligations for reproductive toxins.
- Work Health and Safety Regulations 2017 (Vic) Part 7.1 — identical model requirements; WorkSafe Victoria guidance on reproductive hazards at work.
- Work Health and Safety Regulation 2011 (Qld) Part 7.1 — identical framework; SafeWork Qld has issued specific guidance on WAG in healthcare settings.
- Therapeutic Goods Administration — volatile anaesthetic agents registered as Schedule 4 prescription medicines; storage, handling, and disposal obligations under the Poisons Standard.
- ANZCA — Professional Standards apply to anaesthetic machines, scavenging systems, and pre-list checks as part of anaesthetic practice regulation.
Frequently asked questions
Is nitrous oxide still used widely enough to justify WAG controls?
Yes. Despite declining use in some areas, nitrous oxide is still used routinely in dental conscious sedation, obstetric analgesia (Entonox), and some paediatric and adult procedural sedation applications. Desflurane and sevoflurane remain the dominant volatile agents in Australian operating theatres. WAG controls are mandatory wherever any inhalational agent is used, regardless of frequency.
Do TIVA (total intravenous anaesthesia) techniques eliminate WAG risk?
TIVA techniques using propofol and remifentanil infusions with a laryngeal mask airway sealed to a breathing circuit produce negligible WAG because no volatile agent is used. However, if nitrous oxide is added to a TIVA technique for analgesia, WAG risk is reintroduced. Recovery rooms remain a WAG exposure area even for TIVA patients if other patients in the room are recovering from volatile anaesthesia.
How often must WAG air monitoring be conducted?
ANZCA PS31 recommends annual personal exposure monitoring for all high-exposure roles (anaesthetist, scrub/circulating nurse, recovery nurse). Additional monitoring is indicated when: a new machine or scavenging system is installed, a significant circuit change occurs, a worker reports WAG-related symptoms, a pregnancy declaration is received, or a ventilation inspection identifies a reduction in air change rate below AS 1668.2 requirements.
What is the reproductive toxicity threshold for female theatre workers?
The SWA TWA WES for nitrous oxide is 25 ppm (8-hour average). Studies linking spontaneous abortion with occupational nitrous oxide exposure typically involve sustained exposures well above 50 ppm in unscavenged environments. The SWA WES provides a safety margin. However, given the severity of the reproductive endpoint (miscarriage, congenital abnormality), the precautionary approach recommended in ANZCA PS31 is to keep all exposures as low as reasonably practicable, and to assess pregnant workers individually rather than assuming compliance with the group WES is sufficient protection.